Mice with TNBS-induced colitis who were given an FMT from CD patients who achieved remission with vedolizumab exhibited elevated CDCA and LCA levels, leading to increased stimulation of FXR and TGR5, and ultimately alleviating colitis [122]. The gene discussed is GPBAR1; the disease is colitis.